GlassScriptPhysician profile
Kha T Dinh
NPI 1811252075
$13,313.41
in general payments reported to CMS, 2019-2025
21 companies · $7,997 in 2025
The $7,997 reported for 2025 was more than what 94% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $22.76 · 2021: $23.40 · 2022: $1,285 · 2023: $3,437 · 2024: $370 · 2025: $7,997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Education: $3,000 · Honoraria: $2,375 · Travel and Lodging: $1,217 · Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Education | $3,000.00 |
| Honoraria | $2,375.00 |
| Travel and Lodging | $1,217.23 |
| Food and Beverage | $1,211.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maquet Cardiopulmonary Gmbh | $7,483.33 | 2025 | Hls Set |
| Intuitive Surgical, INC. | $3,901.13 | 2022-2023 | Ion |
| Astrazeneca Pharmaceuticals LP | $421.95 | 2022-2025 | Airsupra, Tezspire, Fasenra |
| Insmed, INC. | $273.62 | 2024-2025 | Arikayce |
| Merit Medical Systems INC | $193.10 | 2024 | Aero Stent and Delivery System |
| Abbott Laboratories | $156.56 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Tempus Ai, INC | $147.88 | 2025 | Tempus Pixel |
| Livanova USA, INC. | $123.73 | 2023 | Hemolung Cartridge Kit |
| Astellas Pharma US INC | $113.00 | 2020-2024 | Cresemba |
| Boston Scientific Corporation | $108.44 | 2019 | |
| Erbe USA INC | $93.49 | 2019-2025 | Erbecryo2, Cryo2 |
| Pinnacle Biologics, INC | $71.95 | 2024 | Photofrin |
| Grifols USA, LLC | $47.30 | 2022-2023 | Prolastin-C Liquid |
| Genzyme Corporation | $28.81 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $24.04 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $23.55 | 2019 | |
| Coaptech, INC. | $23.40 | 2021 | |
| Gilead Sciences, INC. | $22.93 | 2019 | |
| Abbvie INC. | $21.09 | 2024 | |
| Body Vision Medical INC. | $17.66 | 2024 | Lungvision |
| Olympus America INC. | $16.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kha Dinh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.